Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 24 (RPL31P24)

Target
RPL31P24
Molecular classification
Other (Pseudogene)
01

Overview

RPL31P24 (ribosomal protein L31 pseudogene 24) is a human pseudogene identified in genomic DNA corresponding to the gene for ribosomal protein L31. Unlike functional ribosomal protein genes, RPL31P24 does not encode a protein and is generally not transcribed or translated. Pseudogenes are sequences in the genome that resemble known genes but typically contain mutations or deletions that prevent them from producing functional proteins. RPL31P24 is mentioned in gene databases and scientific product catalogs because of its genomic presence, but it is not biologically active and has no documented role as a therapeutic target or in disease mechanism[5][7][8][9][11].

Other names
RPL31P24Ribosomal protein L31 pseudogene 24RPL31_11_499
02

Mechanism of action

None (No mechanisms of drug action relevant to this pseudogene)

03

Biological functions

Other (As a pseudogene, RPL31P24 does not have distinct biological function. True ribosomal protein L31 participates in ribosome structure and function, but pseudogenes do not encode a protein product)
04

Disease associations

Other (No known disease associations; some ribosomal protein genes can be associated with rare diseases, but not pseudogenes like RPL31P24)
05

Safety considerations

None (As it is a pseudogene, there are no safety concerns or therapeutic challenges associated with targeting RPL31P24)
06

Interacting drugs

None (There are no known drugs targeting or interacting with this pseudogene)
07

Biomarkers

None (Not established as a biomarker for any condition)

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 24 (RPL31P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 24 (RPL31P24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call